PATENT CLAIM ANALYSIS

Application Number: 16356360
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-09
Patent Classification: ["514", "252030"]

Abstract:
Compounds of Formula 1 as inhibitors of protein tyrosine phosphatase SHP2 are disclosed. The pharmaceutical compositions comprising compounds of Formula 1, methods of synthesis of these compounds, methods of treatment for diseases associated with the aberrant activity of SHP2 such as cancer using these compounds or compositions containing these compounds are also disclosed.

Claim (Index 10):
The compound of  claim 1 , wherein Ring B is optionally substituted 5-((3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl)-6-oxo-1,6-dihydropyrazin-2-yl.

Metadata:
- Claim Count in Document: 39.0
- Percentile: 99.0
- Lexical Diversity: 1.58333
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15736989', '16228324', '15110511', '15899821', '15736925']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7947254810183003
- 35 USC 102 Novelty (BERT): 0.5184721968496752
- Combined Prediction Score: 0.7671001526014378
- Mean Citation Score: 288.909928
- Max Citation Score: 300.6652200000001
- Similarity Product: 203.9111541538096

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test